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Abstract
Background: Nowadays, the histological examination of prostate core needle biopsies is still regarded as the gold
standard in the diagnosis of prostate cancer (PCa). We investigated if the tissue print of core needle biopsy (biopsy
print) could be used as adjunctive molecular investigative procedures in conjunction with routine histological
examination of biopsy to improve PCa diagnosis.
Methods: The direct contact of PCa core biopsy to nitrocellulose membrane resulted in the release of a cellular
micropeel that was used for downstream analytical procedures.
Results: By zymogram print-phoresis we demonstrated that matrix metalloproteases MMP-2 and MMP-9 could be
visualized in biopsy prints and that the gelatinolytic activity was positively correlated with immunohistochemistry
analysis of the same markers in matched bioptic specimens. Moreover, we compared the ability to detect the PCa-
associated hypermethylation of GSTP1 promoter in DNA extracted from biopsy prints with those of the
corresponding core needle biopsies. Biopsy prints demonstrated the same specificity of biopsies in detecting PCa
(50%) while the sensitivity and the positive predictive value were lower than biopsies (56% vs 78% and 63% vs
70%, respectively).
Conclusions: Biopsy print, combining a molecular point of view to the routinely hystopathological analysis of
prostate biopsies, should be a useful tool to improve the diagnosis of PCa.
Introduction
To date, the diagnosis of prostate cancer (PCa) is based
upon the histological examination of prostate core nee-
dle biopsies. Other diagnostic procedures, although use-
ful in improving the detection of PCa, such as measure
of serum prostate specific antigen (PSA), still lack in
adequate specificity to be used alone as diagnostic tech-
nique. The importance of prostate needle biopsies is
supported by the continuous progress in biopsy scheme
in the attempt to improve the detection rate of PCa. In
fact, in the last few years the standard sextant biopsy
has been replaced by 12 cores and even more extensive
biopsy schemes [1,2]. Despite the current debate on the
optimal biopsy scheme, the core needle biopsy is still
regarded by urologists as the gold standard in the diag-
nosis of PCa. Moreover, in the attempt of better detect-
ing PCa, several immunohistochemistry innovations
have been developed, and some markers, as metallopro-
teases, has been associated to the progression of PCa
[3].
The Gleason score offers a good description of the
aggressiveness of the tumor, but it is insufficient in esti-
mating the prognosis. In order to achieve an optimal
therapeutic approach a molecular analysis of needle
biopsy should be useful. However, a single core biopsy,
due to its small size, cannot be reserved for other analy-
tical procedures than pathologic examination. Although
the idea of reproducing an exact anatomical copy of a
tissue on a solid support is not a novelty, it has been
applied mainly in botanic studies [4]. Tissue print is
based on the transfer, by direct contact, of the superfi-
cial cellular contents of a fresh tissue to an adhesive or
adsorptive surface. Tissue print of vegetal tissues on
nylon or nitrocellulose membrane has demonstrated to
be an effective tool to spatially detect the presence of
specific proteins and mRNA [5]. Tissue copies on adhe-
sive surface from rat and mouse tissues have been uti-
lized in DNA-DNA and RNA-RNA hybridization assays
* Correspondence: adriano.angelucci@univaq.it
1Department of Experimental Medicine, University of L’Aquila, L’Aquila,
67100, Italy
Full list of author information is available at the end of the article
Angelucci et al. Diagnostic Pathology 2011, 6:34
http://www.diagnosticpathology.org/content/6/1/34
© 2011 Angelucci et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
and in immunochemistry [6-8]. In more recent studies,
Gaston and colleagues have successfully applied the tis-
sue print technique to the molecular investigation of
PCa biopsy and of the entire prostate surface. They
demonstrated that the cellular micropeel retained on the
membrane is enough to detect proteins and mRNA in a
wide range of application, from print-phoresis to RT-
PCR [9].
Our aim has been to verify whether the biopsy print
should be an adequate copy of the prostate biopsy and
if it may be useful in the routinely clinical diagnostic
investigation as based on an easy procedure and on a
wide range of methods available for its analysis.
Materials and methods
Patients
We selected 18 consecutive patients with a histological
diagnosis of PCa, who underwent radical retropubic
prostatectomy (RRP) in our Urology Department of the
G. Mazzini Hospital, Teramo, Italy. Patients were eligi-
ble if they did not undergo previous anti-hormonal,
radiation or chemotherapies. We considered the serum
PSA value at the diagnosis and Gleason score obtained
after RRP. As controls we enrolled 6 patients affected by
Benign Prostatic Hyperplasia (BPH) and diagnosed by
the histopathological analysis of the tissue obtained after
a transvescical retropubic adenomectomy (TV adeno-
mectomy) or a transurethral resection prostatectomy
(TURP). Our institutional review board approved the
protocol. All patients signed the informed consent.
Reagents and plasticware
Reagents, if not differently indicated, were purchased
from Sigma-Aldrich (St. Luois, MI, USA). Plasticware
was purchased by BD Biosciences (Franklin Lakes, NJ
USA). Human prostate cancer cell line, PC3 was origin-
ally obtained by ATCC (Rockville, MD, USA) and main-
tained in DMEM supplemented with 10% fetal bovine
serum (FBS), glutamine, and penicillin-streptomycin.
Conditioned medium was obtained culturing PC3 cells
for 48 h in FBS-free medium.
Biopsy and tissue print
Three needle biopsies were performed immediately after
the surgical treatment in the area where the tumor was
localized. All the procedures were performed in aseptic
atmosphere. Immediately, all three bioptic tissues were
completely rinsed in phosphate buffer without Ca2+ and
Mg2+ and then the excess of liquid was dried off by an
absorbent paper. Each of the three biopsies were spread
on a dry nitrocellulose membrane (0.2 μm Protran,
Whatman plc, Kent, UK) and left to adhere for about 30
seconds. Then were delicately recovered with tweezers
pulling the tissue from one end. The exceeding parts,
without the print, were removed from nitrocellulose
membranes. The resulting biopsy prints were conserved
in a dry box at -20°C until processed.
Zymogram print-phoresis
Gelatin zymogram was performed according to standard
procedure with few modifications. A 10% SDS-polyacry-
lamide gel copolymerized with 0.1 mg/ml gelatine was
utilized placing tissue print on the top of the resolving
gel and then pouring the 6% SDS-polyacrylamide stack-
ing gel. At the end of the run gel was washed three
times with 50 mM Tris-HCl (pH 7.4) containing 2% Tri-
ton X-100 for 15 minutes under agitation to remove
SDS, and was incubated with Tris-HCl (pH 7.4) plus
10 mM CaCl2 and 200 mM NaCl for 24 hours at 37°C.
Gel was then fixed and stained with 0.1% Coomassie
Blue solution. Enzyme digested regions were identified
as white bands against a blue background.
Immunohistochemistry
The three core needle biopsies were fixed in 4% formal-
dehyde in 0.1 M phosphate buffer, pH 7.2, and
embedded in paraffin. Slide-mounted tissue sections
were incubated with the anti-MMP2 or anti-MMP9 pri-
mary antibodies (Santa Cruz, CA, USA) for 1 h at room
temperature. Antibody binding was revealed using the
Ultra-Vision detection system anti-Polyvalent HRP/dia-
minobenzidine kit according to the manufacturer’s
instructions. Each case was evaluated blindly by two
independent readers (A. A. and P. G.). The number of
cells expressing the marker was assessed using a semi-
quantitative three-grade scale (score 0 = 0%, score 1 =
0-50%, or score 2 >50%). Cases in which the two obser-
vers had obtained different results were collectively
reviewed, and a consensus was obtained.
Methylation-specific PCR
The three needle biopsies obtained by focusing on the
area of the tumor and the related tissue prints were
incubated with lysis buffer (10 mmol/L Tris-HCl, pH
8.0, 0.1 mmol/L EDTA, 1% v/v SDS) containing 2 mg/
ml proteinase K at 55°C for 4 h. DNA was then
extracted with 1:1 v/v phenol/chloroform and precipi-
tated with 50 mmol/L sodium acetate in ethanol. The
concentration of extracted DNA was measured with
spectrometry, and a range of 50-150 ng DNA was used
in the following steps. Using the EpiTec Bisulfite Kit
(Qiagen, Venlo, The Netherlands) DNA was modified
by bisulfite treatment for the detection of methylated
CpG residues, and was purified prior of the PCR ampli-
fication. Bisulfite-converted DNA was subjected to
methylation-specific PCR (MSP) using primers specific
for the hypermethylated form of glutathione-S-trans-
pherase 1 (GSTP1) promoter (forward: 5’-
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GTTGCGCGGCGATTTC- 3’; reverse: 5’-GCCCCAA-
TACTAAATCACGACG- 3’ ). The PCR reaction was
performed with 2.5 μl of bisulfite-modified DNA tem-
plate in 25 μl of reaction mixture containing 2.5 μl 10 ×
PCR buffer, 200 μmol/L of each dNTP, 3.0 mmol/L
MgCl2, 0.25 μmol/L each primer, 1.25 U of Ampli Taq
Gold. The PCR reaction was subjected to hot start at
95°C for 10 minutes followed by 30 cycles of denatura-
tion at 95°C for 30 seconds, annealing at 60°C for 1
minute, and extension at 72°C for 1 minute. A second
set of primers detecting an unrelated not methylated
gene, MYOD1 was used as control for the efficacy of
bisulfite conversion (forward: 5’-CCAACTC-
CAAATCCCCTCTCTAT-3’; reverse: 5’-TGATTAATT-
TAGATTGGGTTTAGAGAAGGA-3’). Ten microL of
each PCR reaction were loaded onto a 1.8% agarose gel
containing ethidium bromide and PCR amplified DNA
was visualized by UV transilluminator.
Statistical analysis
SPSS for Windows (version 10.0.7) computer package
was used for statistical analysis of the data. The study
variables were normally distributed (Shapiro-Wilk test; P
< 0.05). The Pearson’s correlation test was used. We
also evaluated the positive predictive value (PPV), the
negative predictive value (NPV), the sensitivity and spe-
cificity of the performed method (biopsy print) with
95% Coefficient of Confidence (CI). Values < 0.01 were
considered significant.
Results
Tissue print collection and print-phoresis from prostate
biopsy
We collected the tissue prints from the biopsies of pros-
tate gland performed after RRP, TURP and TV adeno-
mectomy. At least three different needle biopsies were
performed in the tumour region by the same automatic
biopsy gun used in routinely diagnostic procedures. The
biopsy cores were about 15 mm in length and 1 mm wide
(Figure 1a). Biopsy prints were obtained by spreading the
biopsy cores on the nitrocellulose membrane. Once biopsy
was removed, the presence of a cellular micropeel, copy of
the biopsy surface, could be evidenced by toluidine stain-
ing (Figure 1b). Tissue print can be subjected to SDS-
PAGE embedding it in the stacking gel (print-phoresis,
Figure 1c). At the end of the electrophoretic run, gels were
stained, according to standard procedures, with Coomassie
blue or with silver staining (Figure 1c). Both staining pro-
cedures evidenced the presence of proteins migrated from
the entire length of the tissue print.
Zymogram analysis of biopsy print
Biopsy prints were subjected to zymogram PAGE for the
detection of gelatinolytic activity. Not all the biopsy
prints demonstrated the presence of the lytic enzymes.
When the gelatinolytic activity was evident we observed
both a diffuse and a discrete lytic activity. The more fre-
quent discrete bands were identified as MMP-2 and
MMP-9 (pro- and active forms), as suggested by the
correspondence with the gelatinolytic pattern by condi-
tioned media from PC3 cells (Figure 2). Immunohisto-
chemistry analyses of needle biopsies used for tissue
prints were performed for verifying the presence of
MMP-2 and MMP-9 and the results were expressed in a
semiquantitative scale of intensity (BS, see material and
methods). In order to analyze the relationship between
gelatinolytic pattern in biopsy prints and the grading of
prostate tumours we categorized the results obtained by
zymogram analysis according to the following relative
score (gelatinolytic score, GS): 0 for no gelatinolytic
activity; 1 for diffuse gelatinolytic activity; 2 for discrete
gelatinolytic activity (MMP-2 or MMP-9). Three differ-
ent biopsy prints from the same patients were consid-
ered and the sum of GS and BS were calculated.
According to this procedure we found a significant cor-
relation between GS and BS (r = 0.97, p < 0.01) and
between GS and the Gleason score (r = 0.86, p < 0.01),
Figure 1 Tissue print and print-phoresis. (A) Photograph of two
representative core needle biopsies. (B) The biopsy prints were
incubated with 0.1% toluidine blue solution for five minutes. After
two washing in phosphate buffer the prints were visualized as blue
regions. (C) Schematic representation of the SDS-PAGE print-
phoresis. Biopsy print has been put on the top of the resolving gel,
and embedded in the stacking gel. Representative resolving gels
were stained with Coomassie blue (left) or with silver solution (right)
in order to visualize the protein content. On the top of each gel the
position of the tissue print is shown.
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but not between GS and PSA value (Table 1). Also three
biopsy prints from adenomas were analyzed by zymo-
graphy, but in all cases no enzymatic activity was
detected (Table 1).
GSTP1 methylation analysis of biopsy print
Biopsy print can be used as source for DNA. At least 30
ng of genomic DNA from each biopsy print were recov-
ered by extraction with proteinase K and its integrity
and purity were comparable to DNA extracted by corre-
sponding biopsy (Figure 3a). DNA was subjected to
bisulfite conversion and clean-up and then amplified by
PCR using specific primers for hypermethylated regions
in the promoter of GSTP1 gene. The electrophoretic
run of PCR products determined the presence of a
unique amplified band that was of the same size in
biopsies and in biopsy prints (Figure 3b). We analyzed
for the presence of hypermethylated GSTP1 27 biopsies
derived from 9 different patients and the corresponding
27 biopsy prints (Figure 3c). Moreover we analyzed 9
biopsies and corresponding biopsy prints from 3 differ-
ent BPH, but all these samples resulted negative (data
not shown). The concordance between biopsies and
biopsy prints was of 85% (23/27). The discordances
were observed only in 4 biopsy prints obtained by posi-
tive biopsies and that resulted negative. According to
the data obtained, and considering BPH (6 patients) as
negative controls, we compared the sensitivity, specifi-
city, positive predictive value (PPV) and negative predic-
tive value (NPV) of the biopsies and of the biopsy prints
based on the three needle biopsies, performed on the
area of the tumor, obtained for each of the 18 patients
with an histopathological diagnosis of PCa after RRP
(Table 2). These parameters were calculated considering
positive those patients who had at least one biopsy (or
biopsy print) positive for GSTP1 hypermethylation. The
specificity of the two procedures resulted identical while
the PPVs were comparable.
Discussion
Our study indicates that prostate core needle biopsy
may be printed on a nitrocellulose membrane obtaining
a cellular micropeel useful for several analytical proce-
dures. Tissue print is easy and rapid to be performed
without damaging the tissue, and it has been applied in
numerous cellular models and with different experimen-
tal objectives.
Besides the technical application used, studies with tis-
sue print can be divided into two categories: those
focused on the spatial localization of the marker, and
Figure 2 Zymogram analysis of biopsy prints . Two
exemplificative gels, each one containing two tissue prints visible as
dark strips in the stacking gel, are shown. The presence of discrete
gelatinolytic activity is indicated on the left with the molecular
weight or with the corresponding gelatinase. On the right the
gelatinolytic pattern observed in conditioned medium from PC3
cells.
Table 1 Gelatinolytic score calculated for biopsy prints of PCa and BPH biopsies
Gleason Score PSA (ng/ml) Biopsy MMP9+MMP2 score (BS) Gelatinolytic score (GS) Correlation
PCa 9 7.0 5+2 4 BS vs GS = 0.97 * Gleason vs GS = 0.86 *
PSA (PCa) vs GS = 0.02
PSA (all) vs GS = 0.36
PCa 8 6.0 5+1 4
PCa 8 14.2 3+2 3
PCa 7 8.3 3+0 2
PCa 6 26.0 3+1 2
PCa 6 8.2 2+0 0
PCa 6 14.8 3+1 2
PCa 6 5.9 0 0
PCa 6 10.5 1+1 1
BPH – 3.0 0 0
BPH – 0.4 0 0
BPH – 3.2 0 0
In the corresponding needle biopsies MMP2 and MMP9 expressions were evaluated by immunohistochemistry and a semiquantitative score (BS) was calculated.
Correlation coefficients between BS and GS, between GS and Gleason score and between GS and PSA are shown. The correlation coefficient was calculated for
all PSA values or only for PSA values from PCa patients (* p< 0.01)
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those looking for the presence of the marker. Tissue
print can be utilized in hybridization assays or in histo-
chemistry, detecting the position of the marker on it.
Alternatively, the adhesive substrate can be used as
source to extract proteins, mRNA or DNA. In this sec-
ond circumstance, the tissue print has the main role of
recovering a small portion of the tissue without affecting
the integrity of the starting tissue. In our study we
applied the second approach, and we demonstrated that
biopsy print represents a suitable technique in recover-
ing an amount of protein and DNA, sufficient to per-
form downstream analytical procedures. However, the
zymogram print-phoresis allows also a spatial analysis of
the specimen; in fact the core needle biopsy has an
orientation “out-inside”, containing prostatic tissue from
the capsule toward the inner zone of the gland. For this
reason, after marking the outer extremity of the biopsy,
we may have a representation of the localization of gela-
tinolytic activity along the axis out-inside. In our preli-
minary study we frequently observed a non
homogeneous MMPs localization in the biopsy print
suggesting that a spatial differentiation in gelatinolytic
activity could be possible.
Gelatin zymogram analysis was chosen because it is a
relatively inexpensive technique that allows having
unequivocal results. Moreover, this technique does not
require the processing of the biopsy print, avoiding the
loss or modification of the starting material. Moreover,
it is well known that production of MMP-2 and MMP-9
in PCa cells is associated to tumor invasion and progres-
sion [3]. A significant correlation between the produc-
tion of gelatinases and the Gleason score, but not
between gelatinases and PSA values, was found. In order
to limit the variability observed in the biopsy prints also
from the same prostate gland, we analyzed at least three
different biopsy prints. The highest gelatinolytic score
assigned to the presence of discrete electrophoretic
bands was always associated to specimens with a higher
Gleason grade, while biopsy prints from BPH were
always negative.
We performed the biopsy print in order to verify
whether the DNA extracted from the prints was suffi-
cient to detect the hypermethylation status of the
GSTP1 promoter by methylation-specific PCR (MSP).
The pattern of hypermethylation represents one of the
most promising advancements in tumor diagnostic
methods. Hypermethylation of CpG island sequences
leads to gene silencing by preventing gene transcription
and in human PCa cells, somatic GSTP1 CpG island
hypermethylation and loss of GSTP1 expression appears
Table 2 Predictive parameters for PCa diagnosis associated to GSTP1 hypermethylation analysis in biopsy and in
biopsy print
Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI)
Biopsy 77.8
(45.3-93.7)
50.0 (18.7-81.2) 70.0 (39.7-89.2) 60.0 (23.1-88.2)
Biopsy print 55.6 (26.7-81.1) 50.0 (18.7-81.2) 62.5 (30.6-86.3) 42.9 (15.8-75.0)
(CI = confidence interval).
Figure 3 DNA extraction from biopsy print and GSTP1 hypermethylation analysis. (A) DNA was obtained from the biopsy print and from
the corresponding biopsy and 1/5 of total DNA volume was subjected to electrophoresis run in 1.8% w/v agarose gel. (B) PCR-amplified
products from bisulfite converted DNA were subjected to electrophoretic separation in agarose gel. DNA was extracted from three different
biopsy prints (P) and the related biopsies (B) of the same patient (#1 as in 3C). (C) GSTP1 methylation status in PCa patients evaluated in three
different biopsy prints and related biopsies (+ = GSTP1 hypermethylation).
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to be the most common and consistent genome
abnormality [10,11]. In our study, we obtained DNA
amounts sufficient for MSP in all 27 PCa biopsy prints
examined. We detected hypermethylation in GSTP1
promoter in 78% of patients (7/9), a value that is similar
to those observed by other authors in PCa tissue [12].
The sensitivity of biopsy print-MSP resulted lower than
those of biopsy-MSP (56% vs 79%). The decrease in sen-
sitivity is due to a lower number of hypermethylation-
positive biopsy prints respect to positive biopsies. This
result should be probably accounted to the fact that the
tissue print is a partial representation of the biopsy, and
it collects DNA just from a limited portion of the tissue
biopsy. For this reason if the printed tissue surface does
not contain tumor cells or it contains tumor cells in a
very low percentage, the tissue print may result negative
also in presence of a positive biopsy. The decrease in
sensitivity should be minimized by analyzing multiple
biopsy prints from the same patient. On the contrary,
we did not observe false positive in biopsy print sam-
ples, confirming the specificity of the biopsy analysis.
Both urologists and histopathologist point of view,
who routinely work with us as a well integrated
research group, underline that the future handling of
patients with localized prostate cancer will undoubt-
edly depend upon a more sophisticated prognostication
than that available today. The basis will continue to be
the histopathological evaluation of tumor size, grade,
localization and distribution within the gland unless
the future need for objective techniques is well recog-
nized. The option of combining an histopathological
analysis of prostate biopsies to molecular information
should be of importance in improving the current
diagnostic procedures available, particularly in uncer-
tain cases. Focusing on tissue print of prostate biop-
sies, the results of the current study are undoubtedly
interesting unless need to be confirmed by the use in
the clinical practise to verify whether it is really useful
for the diagnosis of PCa. Because of widely adopted
screening programs for the early detection of prostate
cancer, several patients who undergo RP are diagnosed
with tumors of small volume, and their extent and dis-
tribution in the gland can only be determined by a
microscopic examination of the surgical specimen. His-
torically, one of the most important predictor of can-
cer control following RP is the absence of cancer at
the surgical margins. Tissue print may be able in
increasing specificity of the conventional histopathol-
ogy mainly into the assessment of RP margins as it is a
method for obtaining molecular information about the
cancer that can add to the macroscopic and micro-
scopic anatomical findings.
An important limitation of the present study is the
low number of cases examined. However, this study has
to be considered preliminary and performed in the
attempt to check the methodology. In this regard we try
to point out the promising aspects of the proposed
methodology: first, biopsy print is a very simple and
quick procedure that can be performed soon after the
biopsy. The resulting print can be stored at -20°C until
the execution of the analytic procedure, while the core
needle biopsy can be processed for the histological ana-
lysis. Second, biopsy print resulted in an accurate copy
of the needle biopsy offering reliable molecular informa-
tion about the prostatic tissue. In conclusion, the appli-
cation of biopsy print to a larger number of cases will
clarify whether this promising technique should be use-
ful in supporting the current procedures used for the
diagnosis of PCa.
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